OPIOID-RECEPTOR ANTAGONISTS IN TRANSDERMAL SYSTEMS HAVING BUPRENORPHINE

摘要

The invention relates to opioid-receptor antagonists such as, for example, naloxone in transdermal forms of administration at least containing buprenorphine as an active principle.